289 related articles for article (PubMed ID: 25137612)
1. Collagen and related extracellular matrix proteins in atherosclerotic plaque development.
Shami A; Gonçalves I; Hultgårdh-Nilsson A
Curr Opin Lipidol; 2014 Oct; 25(5):394-9. PubMed ID: 25137612
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
[TBL] [Abstract][Full Text] [Related]
3. Vascular extracellular matrix in atherosclerosis.
Chistiakov DA; Sobenin IA; Orekhov AN
Cardiol Rev; 2013; 21(6):270-88. PubMed ID: 23422022
[TBL] [Abstract][Full Text] [Related]
4. Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability.
Hutcheson JD; Maldonado N; Aikawa E
Curr Opin Lipidol; 2014 Oct; 25(5):327-32. PubMed ID: 25188916
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor is associated with a stable atherosclerotic plaque phenotype and is involved in plaque stabilization after stroke.
Leeuwis JW; Nguyen TQ; Theunissen MG; Peeters W; Goldschmeding R; Pasterkamp G; Vink A
Stroke; 2010 Dec; 41(12):2979-81. PubMed ID: 20966418
[TBL] [Abstract][Full Text] [Related]
6. Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes.
Edsfeldt A; Gonçalves I; Grufman H; Nitulescu M; Dunér P; Bengtsson E; Mollet IG; Persson A; Nilsson M; Orho-Melander M; Melander O; Björkbacka H; Nilsson J
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2143-50. PubMed ID: 25035341
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting extracellular matrix metalloproteinase inducer maybe beneficial for diminishing the atherosclerotic plaque instability.
Xie S; Nie R; Wang J
J Postgrad Med; 2009; 55(4):284-6. PubMed ID: 20083879
[TBL] [Abstract][Full Text] [Related]
8. Exploring the role of extracellular matrix proteins to develop biomarkers of plaque vulnerability and outcome.
Holm Nielsen S; Jonasson L; Kalogeropoulos K; Karsdal MA; Reese-Petersen AL; Auf dem Keller U; Genovese F; Nilsson J; Goncalves I
J Intern Med; 2020 May; 287(5):493-513. PubMed ID: 32012358
[TBL] [Abstract][Full Text] [Related]
9. Detection of altered extracellular matrix in surface layers of unstable carotid plaque: an optical spectroscopy, birefringence and microarray genetic analysis.
Korol RM; Canham PB; Liu L; Viswanathan K; Ferguson GG; Hammond RR; Finlay HM; Baker HV; Lopez C; Lucas AR
Photochem Photobiol; 2011; 87(5):1164-72. PubMed ID: 21699546
[TBL] [Abstract][Full Text] [Related]
10. Role of oncostatin-M in ECM remodeling and plaque vulnerability.
Patel P; Rai V; Agrawal DK
Mol Cell Biochem; 2023 Nov; 478(11):2451-2460. PubMed ID: 36856919
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA regulation of extracellular matrix components in the process of atherosclerotic plaque destabilization.
Kowara M; Cudnoch-Jedrzejewska A; Opolski G; Wlodarski P
Clin Exp Pharmacol Physiol; 2017 Jul; 44(7):711-718. PubMed ID: 28440887
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Matrix Vesicles Mediating Calcification Transition in Diabetic Plaque.
Wang Z; Zhang L; Sun Z; Shao C; Li Y; Bao Z; Jing L; Geng Y; Gu W; Pang Q; Li L; Yan J
Heart Lung Circ; 2020 Jan; 29(1):112-117. PubMed ID: 31230870
[TBL] [Abstract][Full Text] [Related]
13. Proteinases and plaque rupture: unblocking the road to translation.
Newby AC
Curr Opin Lipidol; 2014 Oct; 25(5):358-66. PubMed ID: 25089553
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging of the extracellular matrix in the context of atherosclerosis.
Reimann C; Brangsch J; Colletini F; Walter T; Hamm B; Botnar RM; Makowski MR
Adv Drug Deliv Rev; 2017 Apr; 113():49-60. PubMed ID: 27639968
[TBL] [Abstract][Full Text] [Related]
15. Matricellular proteins in atherosclerosis development.
Pervaiz N; Kathuria I; Aithabathula RV; Singla B
Matrix Biol; 2023 Jun; 120():1-23. PubMed ID: 37086928
[TBL] [Abstract][Full Text] [Related]
16. Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome.
Peeters W; Moll FL; Vink A; van der Spek PJ; de Kleijn DP; de Vries JP; Verheijen JH; Newby AC; Pasterkamp G
Eur Heart J; 2011 Sep; 32(18):2314-25. PubMed ID: 21289041
[TBL] [Abstract][Full Text] [Related]
17. Mouse models of plaque rupture.
Matoba T; Sato K; Egashira K
Curr Opin Lipidol; 2013 Oct; 24(5):419-25. PubMed ID: 23942269
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis formation on atherosclerotic lesions and plaque rupture.
Badimon L; Vilahur G
J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
Johnson JL
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
[TBL] [Abstract][Full Text] [Related]
20. Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque.
Kowara M; Cudnoch-Jedrzejewska A
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
